39.78
price up icon0.08%   0.03
after-market Dopo l'orario di chiusura: 39.78
loading

Centessa Pharmaceuticals Plc Adr Borsa (CNTA) Ultime notizie

pulisher
May 22, 2026

Eli Lilly, Centessa Pharmaceuticals receive US green light - MLex

May 22, 2026
pulisher
May 22, 2026

HSR waiting period lapses for Centessa (CNTA) sale to Eli Lilly under UK scheme - Stock Titan

May 22, 2026
pulisher
May 17, 2026

LLY to buy neuroscience biotech Centessa Pharmaceuticals in $7.8B deal - MSN

May 17, 2026
pulisher
May 11, 2026

Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plcCNTA - ChartMill

May 11, 2026
pulisher
May 07, 2026

Centessa (NASDAQ: CNTA) to be acquired by Lilly for $38 plus up to $9 CVR - Stock Titan

May 07, 2026
pulisher
May 03, 2026

Is It Too Late To Consider Centessa Pharmaceuticals (CNTA) After A 191% One Year Surge? - Yahoo Finance

May 03, 2026
pulisher
May 01, 2026

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026 - GlobeNewswire Inc.

May 01, 2026
pulisher
Apr 30, 2026

Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 12-Month HighStill a Buy? - MarketBeat

Apr 30, 2026
pulisher
Apr 29, 2026

Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals and other big stocks moving higher on Tuesday - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

Centessa (NASDAQ: CNTA) schedules 2026 AGM and advisory pay vote - Stock Titan

Apr 29, 2026
pulisher
Apr 27, 2026

38,432 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Acquired by B. Metzler seel. Sohn & Co. AG - MarketBeat

Apr 27, 2026
pulisher
Apr 27, 2026

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Short Interest Down 47.5% in April - MarketBeat

Apr 27, 2026
pulisher
Apr 20, 2026

Wells Fargo Downgrades Centessa Pharmaceuticals ADR to Equal Weight From Overweight, Adjusts Price Target to $42 From $35 - marketscreener.com

Apr 20, 2026
pulisher
Apr 17, 2026

Lilly to buy Centessa (NASDAQ: CNTA) for $38/ share plus $9 CVR - Stock Titan

Apr 17, 2026
pulisher
Apr 17, 2026

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Apr 17, 2026
pulisher
Apr 10, 2026

Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? - Finviz

Apr 10, 2026
pulisher
Apr 08, 2026

Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders? - Sahm

Apr 08, 2026
pulisher
Apr 05, 2026

Free cash flow per share of Centessa Pharmaceuticals PLC ADR – MUN:260 - TradingView

Apr 05, 2026
pulisher
Apr 04, 2026

Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy - Sahm

Apr 04, 2026
pulisher
Apr 03, 2026

This Akamai Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Sahm

Apr 03, 2026
pulisher
Apr 02, 2026

Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High – What’s Next? - Defense World

Apr 02, 2026
pulisher
Apr 02, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA) - Sahm

Apr 02, 2026
pulisher
Apr 01, 2026

Centessa Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:CNTA) - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume IncreaseHere's What Happened - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal - Yahoo Finance

Apr 01, 2026
pulisher
Apr 01, 2026

JPMorgan Chase & Co. Sells 186,539 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat

Apr 01, 2026
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
Capitalizzazione:     |  Volume (24 ore):